| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.38 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |